Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 41

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 41
---
2024, Mr. Lisicki was promoted to the role of Chief Executive Officer and joined the Board as a non-independent director. (5) Dr. Sidhu transitioned from his role as the Company’s Chief Executive Officer, effective April 8, 2024, and continues to serve on the Board as a non-independent director. (6) The cash amounts reported in this table for Dr. Sidhu and Dr. Nistala for 2024 have been converted from GBP to USD using the average exchange rate for the year ended December 31, 2024 of 1 GBP = USD$1.28. (7) Ms. Davis was appointed Chief Operating Officer effective February 27, 2025. Narrative to the Summary Compensation Table We review compensation annually for all employees, including our named executive officers. In setting our named executive officers’ base salaries and bonuses and granting equity incentive awards, we seek to align pay for performance and consider, among other factors, compensation for comparable positions in the market, the historical compensation levels of our named executive officers, individual performance as compared to our expectations and objectives, our desire to motivate our named executive officers to achieve short- and long-term results that are in the best interests of our shareholders, and a long-term commitment to our company. Base Salaries Our named executive officers receive a base salary to compensate them for services rendered to us. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive’s skill set, experience, role and responsibilities. None of our named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base salary. See “— Employment Arrangements with Our Named Executive Officers” for additional information. The following table sets forth the annual base salaries for our named executive officers for 2023 and 2024, at year end, or, in the case of Dr. Sidhu, the date of his termination as Chief Executive Officer:

| Name               | ​ | ​ | 2023 BaseSalary Rate($) |   |         |   | ​ | ​ | 2024 BaseSalary Rate($) |   |         |   | ​ |
| Robert Lisicki(1)  | ​ | ​ | ​                       | ​ |       — | ​ | ​ | ​ | ​                       | ​ | 585,000 | ​ | ​ |
| Someit Sidhu(2)(3) | ​ | ​ | ​                       | ​ |